Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,493Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ABEX Pharmaceutica

02 2ACS DOBFAR SPA

03 2Actavis Inc

04 1Antibiotice SA

05 2Aurobindo Pharma Limited

06 1Austell Laboratories

07 1Bernofarm Pharmaceutical Company

08 2Brooks laboratories Limited

09 2Fresenius SE & Co. KGaA

10 1HQ SPCLT PHARMA

11 3Health Biotech

12 1Hikma Pharmaceuticals

13 5Hospira, Inc.

14 1Jeil Pharmaceutical Co., Ltd

15 1Jodas Expoim Pvt. Ltd

16 1MSD INTL GMBH

17 1Macleods Pharmaceuticals Limited

18 9Merck & Co

19 1Myungmoon Pharm. Co., LTD.

20 1ORIFARM GROUP AS

21 1Pharma Dynamics

22 2RANBAXY LABORATORIES LIMITED

23 2Sandoz B2B

24 2Sun Pharmaceutical Industries Limited

25 1Tamrisa

26 1Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : IMIPENEM AND CILASTATIN

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 250MG BASE/VIAL;250MG/VIAL

Packaging :

Approval Date : 2011-12-21

Application Number : 90577

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : IMIPENEM AND CILASTATIN

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL

Packaging :

Approval Date : 2011-12-21

Application Number : 90577

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Imipenem; Cilastatin

Brand Name : Imipenem And Cilastatin

Dosage Form : Imipenem+Cilastatin+500500 Mg 10 Units Parenteral Use

Dosage Strength : 10 VIALS EV 500 mg + 500 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Imipenem; Cilastatin

Brand Name :

Dosage Form : Injection

Dosage Strength : 250MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Imipenem; Cilastatin

Brand Name : Imecitin

Dosage Form : Imipenem+Cilastatin+500500 Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial EV 500 mg + 500 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Imipenem; Cilastatin

Brand Name : Imipenem And Cilastatin

Dosage Form : Imipenem+Cilastatin+500500 Mg 10 Units Parenteral Use

Dosage Strength : 10 vials soluz Chk 500 mg + 500 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : IMIPENEM AND CILASTATIN

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 250MG BASE/VIAL;250MG/VIAL

Packaging :

Approval Date : 2011-11-16

Application Number : 90825

Regulatory Info : DISCN

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : IMIPENEM AND CILASTATIN

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL

Packaging :

Approval Date : 2011-11-16

Application Number : 90825

Regulatory Info : DISCN

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : IMIPENEM AND CILASTATIN

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL

Packaging :

Approval Date : 2011-11-16

Application Number : 91007

Regulatory Info : DISCN

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : IMIPENEM AND CILASTATIN

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL

Packaging :

Approval Date : 2019-12-12

Application Number : 207594

Regulatory Info : RX

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cilastatin; Imipenem

Brand Name :

Dosage Form : INJECTION;

Dosage Strength : 0.5MG; 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Imipenem; Cilastatin

Brand Name :

Dosage Form : Powder for Injection

Dosage Strength : 250MG; 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : PRIMAXIN

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 250MG BASE/VIAL;250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1985-11-26

Application Number : 50587

Regulatory Info : DISCN

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : PRIMAXIN

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL

Packaging :

Approval Date : 1985-11-26

Application Number : 50587

Regulatory Info : RX

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : PRIMAXIN

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL

Packaging :

Approval Date : 1990-12-14

Application Number : 50630

Regulatory Info : DISCN

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : PRIMAXIN

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : EQ 750MG BASE/VIAL;750MG/VIAL

Packaging :

Approval Date : 1990-12-14

Application Number : 50630

Regulatory Info : DISCN

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : PRIMAXIN

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 250MG BASE/VIAL;250MG/VIAL

Packaging :

Approval Date : 1987-01-08

Application Number : 62756

Regulatory Info : DISCN

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM

Brand Name : PRIMAXIN

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL

Packaging :

Approval Date : 1987-01-08

Application Number : 62756

Regulatory Info : DISCN

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Brand Name : RECARBRIO

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL;250MG/VIAL

Packaging :

Approval Date : 2019-07-16

Application Number : 212819

Regulatory Info : RX

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Imipenem; Cilastatin Sodium

Brand Name : Tipem

Dosage Form : INJECTION

Dosage Strength : 530MG; 532MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank